Corpus Intelligence IC Memo — ST. JOSEPHS MEDICAL CENTER 2026-04-26 05:26 UTC
IC Memo — ST. JOSEPHS MEDICAL CENTER
Investment Committee Memorandum | MN | 127 beds | Grade B | EBITDA uplift $20.9M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

ST. JOSEPHS MEDICAL CENTER

CCN 240075 | CROW WING, MN | 127 beds | April 26, 2026
EBITDA BridgeData Room
B
Investability

1. Target Overview & Investment Thesis

ST. JOSEPHS MEDICAL CENTER is a 127-bed suburban community hospital in CROW WING, MN with $283.3M in net patient revenue and a -0.0% operating margin. The hospital serves a payer mix of 30.6% Medicare, 3.1% Medicaid, and 66.2% commercial.

Thesis: Undervalued. Our ML models identify $20.9M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -0.0% to 7.3% (+736bps).

Net Revenue HCRIS$283.3M
Current EBITDA COMPUTED$-37K
Operating Margin COMPUTED-0.0%
Occupancy HCRIS43.5%
Revenue / Bed COMPUTED$2.2M
Net-to-Gross HCRIS41.5%
Distress Probability ML49.4%

2. Market Context & Competitive Position

141
MN Hospitals
-3.6%
State Median Margin
18
Comparable Hospitals

MN has 141 Medicare-certified hospitals with a median operating margin of -3.6%. The target's margin of -0.0% places it above the state median. Among 18 size-comparable peers (64-254 beds), the median margin is -7.1%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (64-254), prioritizing same-state peers. 18 hospitals in the comp set.

HospitalStateBedsRevenueMargin
ST. JOSEPHS MEDICAL CENTER (Target)MN127$283.3M-0.0%
SMDC MEDICAL CENTERMN118$519.2M-7.1%
ST. LUKES HOSPITAL OF DULUTHMN238$494.0M-9.3%
MCHS - SOUTHWEST MINNESOTA REGMN118$473.6M-9.8%
LAKEVIEW MEMORIALMN68$411.9M60.9%
HEALTHEAST ST JOHNS HOSPITALMN184$375.8M-7.7%
FAIRVIEW RIDGES HOSPITALMN172$316.2M7.0%
SANFORD BEMIDJIMN94$312.6M-19.6%
RIDGEVIEW MEDICAL CENTERMN109$287.8M-14.2%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $20.9M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$6.0M+210bp18mo
Cost to Collect4.5%2.5%$5.7M+200bp12mo
Denial Rate Reduction12.0%6.5%$5.6M+198bp12mo
A/R Days Reduction5200.0%3800.0%$3.4M+122bp9mo
Clean Claim Rate88.0%96.0%$181K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$6.0M
Cost to Collect
$5.7M
Denial Rate Reduction
$5.6M
A/R Days Reduction
$3.4M
Clean Claim Rate
$181K
Total EBITDA Uplift$20.9M
Current EBITDA$-37K
+ RCM Uplift+$20.9M
Pro Forma EBITDA$20.8M
Current Margin-0.0%
Pro Forma Margin7.3%
WC Released (1x)$10.9M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-57K$208.3M0.00x-100.0%
Base (11x exit)10.0x11.0x$-57K$229.1M0.00x-100.0%
Bull Case9.0x11.0x$-51K$297.9M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-51K$325.0M0.00x-100.0%
Bear Case11.0x10.0x$-62K$104.1M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-62K$114.4M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 18 hospitals with 64-254 beds
  • Same-state prioritization (n=19)
  • Comp margins: P25=-10.3% / P50=-7.1% / P75=-0.8%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.